ZA885034B - Contraceptive implant - Google Patents

Contraceptive implant

Info

Publication number
ZA885034B
ZA885034B ZA885034A ZA885034A ZA885034B ZA 885034 B ZA885034 B ZA 885034B ZA 885034 A ZA885034 A ZA 885034A ZA 885034 A ZA885034 A ZA 885034A ZA 885034 B ZA885034 B ZA 885034B
Authority
ZA
South Africa
Prior art keywords
contraceptive implant
implant
contraceptive
locally
release
Prior art date
Application number
ZA885034A
Other languages
English (en)
Inventor
Hendrik De Nijs
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=19850428&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA885034(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Akzo Nv filed Critical Akzo Nv
Publication of ZA885034B publication Critical patent/ZA885034B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0092—Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nanotechnology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Prostheses (AREA)
  • Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
ZA885034A 1987-08-08 1988-07-12 Contraceptive implant ZA885034B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL8701868 1987-08-08

Publications (1)

Publication Number Publication Date
ZA885034B true ZA885034B (en) 1989-03-29

Family

ID=19850428

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA885034A ZA885034B (en) 1987-08-08 1988-07-12 Contraceptive implant

Country Status (19)

Country Link
US (3) US4957119A (ko)
EP (1) EP0303306B1 (ko)
JP (1) JP2571831B2 (ko)
KR (1) KR950008763B1 (ko)
CN (1) CN1024753C (ko)
AT (1) ATE86484T1 (ko)
AU (1) AU603475B2 (ko)
CA (1) CA1309949C (ko)
DE (2) DE19975054I2 (ko)
DK (1) DK173166B1 (ko)
ES (1) ES2054784T3 (ko)
FI (1) FI93421C (ko)
HK (1) HK1002020A1 (ko)
IE (1) IE61730B1 (ko)
MX (1) MX9203817A (ko)
NL (1) NL980027I2 (ko)
NZ (1) NZ225399A (ko)
PT (1) PT88220B (ko)
ZA (1) ZA885034B (ko)

Families Citing this family (95)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5114719A (en) * 1987-04-29 1992-05-19 Sabel Bernhard A Extended drug delivery of small, water-soluble molecules
US5156164A (en) * 1988-10-13 1992-10-20 Leveen Harry H Iodine contraceptive sponge
BE1002600A3 (fr) * 1988-11-23 1991-04-09 Wildemeersch Dirk Dispositif intra-uterin perfectionne.
IE71202B1 (en) * 1990-12-17 1997-02-12 Akzo Nv Progestagen-only contraceptive
WO1993017662A1 (en) * 1992-03-02 1993-09-16 Daratech Pty. Ltd. Improved implants
ES2150427T3 (es) * 1992-06-02 2000-12-01 Bard Inc C R Procedimiento y dispositivo de implante para el suministro de farmacos a largo plazo.
US5368588A (en) * 1993-02-26 1994-11-29 Bettinger; David S. Parenteral fluid medication reservoir pump
US5443461A (en) * 1993-08-31 1995-08-22 Alza Corporation Segmented device for simultaneous delivery of multiple beneficial agents
US5681817A (en) 1994-02-04 1997-10-28 The Medical College Of Hampton Roads Treatment of ovarian estrogen dependent conditions
US5660848A (en) * 1994-11-02 1997-08-26 The Population Council, Center For Biomedical Research Subdermally implantable device
US5521166A (en) * 1994-12-19 1996-05-28 Ortho Pharmaceitical Corporation Antiprogestin cyclophasic hormonal regimen
DE19539361A1 (de) * 1995-10-23 1997-04-24 Basf Ag Verfahren zur Herstellung von mehrschichtigen, festen Arzneiformen zur oralen oder rektalen Verabreichung
US5733565A (en) * 1996-02-23 1998-03-31 The Population Council, Center For Biomedical Research Male contraceptive implant
CN1088993C (zh) * 1996-10-11 2002-08-14 上海市计划生育科学研究所 含孕二烯酮的长效皮下避孕埋植剂
US6203813B1 (en) 1997-01-13 2001-03-20 Lance L. Gooberman Pharmaceutical delivery device and method of preparation therefor
TW358031B (en) * 1997-04-11 1999-05-11 Akze Nobel N V Drug delivery system for 2 or more active substances
DE19744135C1 (de) * 1997-09-29 1999-03-25 Schering Ag Beschichtete medizinische Implantate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Restenoseprophylaxe
US6394094B1 (en) 1998-05-01 2002-05-28 Enhance Pharmaceuticals, Inc. Method for injection molding manufacture of controlled release devices
US6117441A (en) * 1998-07-02 2000-09-12 The Population Council, Inc. Silicone core long term androgen delivery implant
EP1098653A2 (en) * 1998-07-17 2001-05-16 PHARMACIA & UPJOHN COMPANY Subcutaneous medroxyprogesterone acetate for contraception
US6117442A (en) * 1998-11-12 2000-09-12 Leiras Oy Drug delivery device, especially for the delivery of androgens
US6063395A (en) * 1998-11-12 2000-05-16 Leiras Oy Drug delivery device especially for the delivery of progestins and estrogens
US6217895B1 (en) * 1999-03-22 2001-04-17 Control Delivery Systems Method for treating and/or preventing retinal diseases with sustained release corticosteroids
CA2267743C (en) * 1999-03-30 2011-07-26 Robert F. Casper Low dose estrogen interrupted hormone replacement therapy
US6375972B1 (en) 2000-04-26 2002-04-23 Control Delivery Systems, Inc. Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
DK1313511T3 (da) * 2000-08-23 2006-03-20 Akzo Nobel Nv Testosteronesterformulering til human brug
JP2006500115A (ja) 2000-11-16 2006-01-05 マイクロスフエリツクス・エル・エル・シー 密封小線源治療用の可撓性および／または弾性シードまたはストランド
JP4866535B2 (ja) 2001-05-11 2012-02-01 オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド 動物で用いるに適した免疫調節用デバイス
ATE319451T1 (de) 2001-07-02 2006-03-15 Akzo Nobel Nv Tetrahydrochinolin-derivate
WO2003017971A1 (en) * 2001-08-31 2003-03-06 Schering Oy Drug delivery system
WO2003020727A1 (en) 2001-09-04 2003-03-13 Akzo Nobel N.V. GLYCINE-SUBSTITUTED THIENO [2,3-d]PYRIMIDINES WITH COMBINED LH AND FSH AGONISTIC ACTIVITY
TWI228508B (en) 2001-09-04 2005-03-01 Akzo Nobel Nv Thieno[2,3-d]pyrimidines with combined LH and FSH agonistic activity
AU2003201410B2 (en) * 2002-01-24 2008-07-03 Virbac Corporation Sustained release pharmaceutical composition
CN1652799A (zh) * 2002-03-11 2005-08-10 詹森药业有限公司 只用抑制硫酸酯酶的孕激素的避孕给药方案
TWI297685B (en) 2002-04-04 2008-06-11 Organon Nv Non-steroidal progesterone receptor modulators
AU2003234439A1 (en) * 2002-05-07 2003-11-11 Control Delivery Systems, Inc. Processes for forming a drug delivery device
US8871241B2 (en) * 2002-05-07 2014-10-28 Psivida Us, Inc. Injectable sustained release delivery devices
US7736665B2 (en) * 2002-05-31 2010-06-15 Titan Pharmaceuticals, Inc. Implantable polymeric device for sustained release of buprenorphine
RU2340345C2 (ru) * 2002-08-28 2008-12-10 Роберт КАСПЕР Схема восполнения эстрогена
US7795280B2 (en) 2002-11-07 2010-09-14 N.V. Organon Indoles useful in the treatment of androgen-receptor related diseases
TWI306855B (en) 2002-12-20 2009-03-01 Organon Nv Tetrahydroquinoline derivatives
TWI322012B (en) 2002-12-20 2010-03-21 Organon Nv Tetrahydroquinoline derivatives
KR101152183B1 (ko) 2003-03-31 2012-06-15 타이탄 파머슈티컬즈 인코퍼레이티드 도파민 아고니스트의 지속 방출을 위한 이식가능한 폴리머디바이스
EP1620060B1 (en) 2003-04-29 2010-03-24 The General Hospital Corporation Methods and devices for the sustained release of multiple drugs
TWI336627B (en) 2003-05-23 2011-02-01 Organon Nv Drug delivery system,and use and manufacturing method thereof
JP2007502866A (ja) * 2003-05-30 2007-02-15 タイタン ファーマシューティカルズ インコーポレイテッド ナルメフェンの持続的放出のための移植可能ポリマー装置
EP1643946A2 (en) * 2003-06-20 2006-04-12 Viral Genomix, Inc. Compositions for and methods for treating hiv
CA2552757A1 (en) * 2004-01-13 2005-08-04 Vasogenix Pharmaceuticals, Inc. Methods of using cgrp for cardiovascular and renal indications
EP1703916A2 (en) * 2004-01-13 2006-09-27 Vasogenix Pharmaceuticals, Inc. Methods for treating acute myocardial infarction by calcitonin gene related peptide and compositions containing the same
CA2552677A1 (en) * 2004-01-13 2005-07-28 Vasogenix Pharmaceuticals, Inc. Controlled release cgrp delivery composition for cardiovascular and renal indications
TWI434676B (zh) 2004-03-19 2014-04-21 Merck Sharp & Dohme 可用ｘ射線看出之藥物遞送裝置
TW200531977A (en) 2004-03-25 2005-10-01 Akzo Nobel Nv Progesterone receptor modulators
TW200602317A (en) 2004-04-23 2006-01-16 Akzo Nobel Nv Novel androgens
PT1629844E (pt) † 2004-07-13 2007-10-17 Bayer Schering Pharma Oy Sistema de distribuição a longo prazo com distribuição súbita inicial controlada
CA2575988C (en) 2004-08-04 2014-02-18 Brookwood Pharmaceuticals, Inc. Methods for manufacturing delivery devices and devices thereof
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
US8394840B2 (en) * 2005-06-15 2013-03-12 Hydra Biosciences, Inc. Modulators of sperm hypermotility and uses thereof
EP1743638A1 (en) 2005-07-15 2007-01-17 Laboratorios Del Dr. Esteve, S.A. Pharmaceutical formulations of substituted pyrazoline compounds
DK2049081T3 (da) 2006-08-09 2013-02-25 Intarcia Therapeutics Inc Osmotiske leveringssystemer og stempelarrangementer
US7989442B2 (en) 2006-09-27 2011-08-02 N.V. Organon Progesterone receptor modulators
CN101209238B (zh) * 2006-12-27 2012-05-09 辽宁省计划生育科学研究院 含孕二烯酮的生物降解型长效皮下避孕埋植剂及其制备
PT2157967E (pt) 2007-04-23 2013-04-03 Intarcia Therapeutics Inc Formulações de suspensões de péptidos insulinotrópicos e suas utilizações
US8063037B2 (en) 2007-05-07 2011-11-22 N. V. Organon Progesterone receptor modulators
CN101130057B (zh) * 2007-07-06 2011-04-27 复旦大学 胸腺五肽长效植入剂及其制备方法
TW200930343A (en) 2007-09-21 2009-07-16 Organon Nv Drug delivery system
EP2227252B1 (en) 2007-11-27 2012-07-25 Nira Hochman Adjuvant comprising vaccinium macrocarpon
EP2222281B1 (en) 2007-12-20 2018-12-05 Evonik Corporation Process for preparing microparticles having a low residual solvent volume
DK2240155T3 (da) 2008-02-13 2012-09-17 Intarcia Therapeutics Inc Indretninger, formuleringer og fremgangsmåder til levering af flere gavnlige midler
KR102148624B1 (ko) 2009-09-28 2020-08-26 인타르시아 세라퓨틱스 인코포레이티드 실질 항정상태 약물 전달의 신속 확립 및/또는 종결
CN102740830A (zh) * 2009-12-23 2012-10-17 普西维达公司 缓释递送装置
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
US10028858B2 (en) 2011-07-11 2018-07-24 Medicines360 Intrauterine systems, IUD insertion devices, and related methods and kits therefor
AR089765A1 (es) * 2012-01-23 2014-09-17 Bayer Oy Un sistema para el suministro de un farmaco
EP2953678B1 (en) 2013-02-06 2020-03-25 Sillender, Mark Therapeutic substance transfer catheter
US10188426B2 (en) 2013-02-06 2019-01-29 Mark SILLENDER Embryo transfer catheter and method
US10413504B2 (en) 2013-12-11 2019-09-17 Merck Sharp & Dohme Corp. Intravaginal ring drug delivery system
US10596103B2 (en) 2013-12-11 2020-03-24 Merek Sharp & Dohme B.V. Drug delivery system for delivery of anti-virals
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
WO2016149561A1 (en) * 2015-03-17 2016-09-22 Oak Crest Institute Of Science Subdermal implants for the sustained delivery of water-soluble drugs
KR20240042548A (ko) 2015-06-03 2024-04-02 인타르시아 세라퓨틱스 인코포레이티드 임플란트 배치 및 제거 시스템들
CN109310743A (zh) 2016-05-16 2019-02-05 因塔西亚制药公司 胰高血糖素受体选择性多肽及其使用方法
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
US9980850B2 (en) 2016-09-29 2018-05-29 Gesea Biosciences, Inc. Bioerodible contraceptive implant and methods of use thereof
KR20190104039A (ko) 2017-01-03 2019-09-05 인타르시아 세라퓨틱스 인코포레이티드 Glp-1 수용체 효능제의 연속적인 투여 및 약물의 동시-투여를 포함하는 방법
US11571328B2 (en) 2018-04-09 2023-02-07 Medicines360 IUD insertion devices
MX2020012458A (es) 2018-05-24 2021-04-28 Celanese Eva Performance Polymers Llc Dispositivo implantable para liberacion sostenida de un compuesto de farmaco macromolecular.
CN111989068A (zh) 2018-05-24 2020-11-24 塞拉尼斯伊娃高性能聚合物公司 用于持续释放大分子药物化合物的可植入器件
US20200261258A1 (en) 2019-02-19 2020-08-20 Medicines360 Devices, systems, methods and kits for insertion and removal of iuds
BR102020007749A2 (pt) 2020-04-17 2021-11-03 Edson Luiz Peracchi Implante subcutâneo reabsorvível de longa duração com liberação controlada de substância farmacologicamente ativa pré-concentrada em polímero para tratamento da endometriose
BR102020010923A2 (pt) 2020-05-29 2021-12-14 Luiz Peracchi Edson Implante subcutâneo reabsorvível de longa duração com liberação prolongada de substância farmacologicamente ativa pré-concentrada em polímero para tratamento da insuficiência adrenal crônica ou hipocortisolismo
BR102020013862A2 (pt) 2020-07-07 2022-01-18 Edson Luiz Peracchi Implante subcutâneo reabsorvível de longa duração com liberação sustentada de substância farmacologicamente ativa pré-concentrada em polímero para tratamento da doença de parkinson
WO2022204771A1 (pt) 2021-03-29 2022-10-06 Edson Luiz Peracchi Implante subcutâneo reabsorvível de longa duração com liberação prolongada de substância farmacologicamente ativa pré-concentrada em polímero para tratamento do hipotireoidismo e processo
CN113209050A (zh) * 2021-05-14 2021-08-06 浙江恒冀制药有限责任公司 基于生物相容性聚合物的长效体内皮埋或内植缓释制剂
GB202401392D0 (en) 2024-02-02 2024-03-20 Imphatec Ltd Implant for delivery of a drug

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3903880A (en) * 1972-08-17 1975-09-09 Alza Corp Intrauterine device for managing the reproductive process
US3926188A (en) * 1974-11-14 1975-12-16 Alza Corp Laminated drug dispenser
US4582052A (en) * 1982-03-23 1986-04-15 Repromed, Inc. Povidone-iodine dispensing fiber
NZ200564A (en) * 1982-05-10 1987-03-06 Ahi Operations Ltd Device for slowly releasing chemicals into body cavities of animals
US4601714A (en) * 1983-07-07 1986-07-22 Burnhill Michael S Vaginal device
US4629621A (en) * 1984-07-23 1986-12-16 Zetachron, Inc. Erodible matrix for sustained release bioactive composition
EP0180264A1 (en) * 1984-10-12 1986-05-07 Akzo N.V. Release system for two or more active substances
US4673565A (en) * 1985-05-03 1987-06-16 E. I. Du Pont De Nemours And Company Pharmaceutical compositions containing hollow fine tubular drug delivery systems
US4720384A (en) * 1985-05-03 1988-01-19 E. I. Du Pont De Nemours And Company Manufacture of hollow fine tubular drug delivery systems

Also Published As

Publication number Publication date
PT88220A (pt) 1989-06-30
EP0303306A1 (en) 1989-02-15
DK173166B1 (da) 2000-02-28
DK438688A (da) 1989-02-09
EP0303306B1 (en) 1993-03-10
IE882118L (en) 1989-02-08
KR950008763B1 (en) 1995-08-08
FI883594A (fi) 1989-02-09
FI93421B (fi) 1994-12-30
US5088505A (en) 1992-02-18
US4957119A (en) 1990-09-18
ES2054784T3 (es) 1994-08-16
HK1002020A1 (en) 1998-07-24
MX9203817A (es) 1992-08-01
JP2571831B2 (ja) 1997-01-16
JPS6470410A (en) 1989-03-15
NL980027I2 (nl) 1999-02-01
CN1024753C (zh) 1994-06-01
NZ225399A (en) 1990-09-26
AU603475B2 (en) 1990-11-15
DE3879031D1 (de) 1993-04-15
DE19975054I2 (de) 2000-04-13
US5150718A (en) 1992-09-29
KR890003360A (ko) 1989-04-14
CN1031323A (zh) 1989-03-01
DK438688D0 (da) 1988-08-05
IE61730B1 (en) 1994-11-30
CA1309949C (en) 1992-11-10
ATE86484T1 (de) 1993-03-15
FI883594A0 (fi) 1988-08-01
AU2044988A (en) 1989-03-02
DE3879031T2 (de) 1993-06-24
FI93421C (fi) 1995-04-10
PT88220B (pt) 1995-03-01
NL980027I1 (nl) 1998-12-01

Similar Documents

Publication Publication Date Title
KR950008763B1 (en) Contraceptive lmplant
PL275334A1 (en) Device for controlling intraocular pressure
GB2206494B (en) Orthoses or prostheses for co-ordinating limb movement
GB8825167D0 (en) Locking mechanism for prosthetic implant
GB2212371B (en) Fiducial implant
DE3877174D1 (de) Bezugssystem zur implantation von kondylaeren knie-totalprothesen.
ZA888298B (en) Surgical fastening systems made from polymeric materials
ZA935569B (en) Controlled release implants
GB8901974D0 (en) Plastic retainer for bearing
DE3173606D1 (en) Orthopedic coupling device
PH31558A (en) Release controlled implantable somatotropin composition.
EP0323522A4 (en) ARTIFICIAL TEAR.
AU2076688A (en) Automatic device for supplying lubricant or similar
GB8816205D0 (en) Safety system for machinery having exposed moving parts
EP0306532A4 (en) DEVICE FOR CORRECTING THE STOPPER OF A SHOVEL.
EP0270575A4 (en) BIO-COMPATIBLE IMPLANTS.
GB8702994D0 (en) Polymeric polyols
Kadima Strategies for the Immobilization of Chloroperoxidase
IE871898L (en) Controlled release drug containing fibres.
IE871940L (en) Controlled release pharmaceutical compositions.
CS206986A1 (en) Joint shallow esp. for implanting artificial joints for the hip
CS543388A1 (en) Splint ofspine for implantation
IE862974L (en) Controlled release compositions.
AR243331A1 (es) Procedimiento para la preparacion de un bloque substancialmente rigido util para controlar o prevenir timpanitis en animales.
IL85679A0 (en) Automatic seatbelt release